Bloom Energy's July Volatility: Short Seller Accusations Collide With Wall Street's Widest Target Spread in Months
Published on 07/14/2026 at 15:53 | Redaktion boerse-global.de
The battle for Bloom Energy’s narrative is playing out in real time, with short sellers and Wall Street analysts each digging in. The fuel-cell maker’s stock has become a battlefield of competing theses, leaving investors to navigate a landscape where price targets range from $217 to $350 and the shares swing by double digits in a single week.
Recent trading reflects the tension. After a 17% rout in the prior week, the stock clawed back to €209 on Tuesday, up 1.46% on the day. On a weekly basis, however, it still sat 11.44% lower. The jolt that set off the latest wave of selling came from two short-seller reports. Hunterbrook Capital published a bearish thesis in early July, quickly drawing a sharp rebuttal from Bloom Energy. Crossroads Capital then confirmed a short position, calling Hunterbrook’s arguments compelling. A second report from Hunterbrook Research — possibly the same entity — accused the company of concealing its reliance on Chinese scandium, a critical metal for its solid-oxide fuel cells.
Bloom Energy pushed back hard. In an SEC filing, it stated that it holds sufficient scandium oxide inventories for current demand and backlog, and that it is not dependent on China. Management also asserted that it has full visibility into its supply chain to support annual fuel-cell production of up to 25 gigawatts. The company labeled the Hunterbrook allegations false and misleading, while reaffirming the integrity of its audited financial statements. On Stocktwits, retail investors remained mostly bullish despite the sell-off.
Should investors sell immediately? Or is it worth buying Bloom Energy?
Analysts, meanwhile, are deeply divided. Several major banks have used the dip to reiterate or even raise their price targets. Susquehanna lifted its target from $293 to $298, maintaining a positive rating. Baird stuck with an Outperform rating and a $310 target. Roth Capital increased its target from $225 to $285 but kept a neutral stance. Jefferies initiated coverage on July 6 with a $246 target and a Hold rating, arguing that the valuation is simply too rich to justify more enthusiasm. The stock jumped roughly 9% on that news. UBS analyst Manav Gupta called the sell-off an attractive buying opportunity, dismissing supply-chain fears as overblown and noting Bloom’s proprietary process to secure scandium.
The dispersion in price targets is stark. Over the past three months, 19 analysts have produced an average target of $287.32, with a range stretching from $217 to $350. Expand the window to 12 months and include 36 analysts, and the average drops to $245.72 — below the stock’s recent trading level of $263.61. That gap underscores how quickly sentiment has shifted in 2026: the three-month average target has been revised upward by 95.39% alone. Still, 21 analysts currently rate the shares a Buy.
Technically, the stock is nursing significant wounds. It trades 32.25% below its 52-week high of €308.50, reached on June 25, and roughly 14% under its 50-day moving average of €243.88 (one source puts that MA at €243.90). The relative strength index hovers around 42, signaling neither overbought nor oversold conditions. But the 30-day annualized volatility exceeds 112%, a figure that explains the violent daily swings. Over a longer lens, the picture is extraordinary: the stock has more than nonupled in 12 months and gained 148% year-to-date, with the distance from its July 2025 low of €20.98 standing near 900%.
Bloom Energy reports second-quarter earnings on July 28 after the close. Until then, the tug-of-war between short sellers and optimistic analysts will likely keep the stock in motion — with the scandium supply-chain dispute and the company’s capacity ramp to 5 gigawatts serving as the twin flashpoints.
Ad
Bloom Energy Stock: New Analysis - 14 July
Fresh Bloom Energy information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
